|
|
|
| Webinar: AI Reality Check in Drug Development: What’s Real and What’s Missing | AI is advancing drug discovery and development, but realizing its full potential depends on reliable, high-quality clinical data. Join Dr. Richard Graham, co-founder of TruTechnologies, and industry experts as they explore where AI is delivering value today, where challenges remain, and how sponsors can build the foundation for more effective AI-driven decisions across the drug development lifecycle. Click here to learn more. |
|
|
|
| RBQM And Centralized Monitoring Need Action | From The Editor | By Dan Schell, Chief Editor, Clinical Leader | After COVID forced sponsors to move faster than ever, many are now confronting a harder challenge: ownership. Marci Thear explains why RBQM and centralized monitoring only work when sponsors move beyond reviewing outputs and start acting on the signals. |
|
|
|
| De-Risking Early Immunology Pipelines | Article | CHDR | Human challenge models reveal immune pathway behavior in controlled settings, linking early research to outcomes and helping confirm target engagement, refine dosing, and reduce development uncertainty. |
|
|
CLINICAL DATA MANAGEMENT & ANALYTICS |
|
|
| Quantifying The Impact Of AI-Enabled Trial Delivery | Video | Clinical Leader | In March 2026, consultants Brian Whitlock and Samir Shah presented data at the TD Cowen Healthcare Conference quantifying the impact of AI-enabled trial delivery on a hypothetical Phase III study. On 4/1/26, Clinical Leader hosted an exclusive webinar summarizing the data Whitlock and Shah presented. The webinar also included Mark Travers and Sheryl Jacobs, two other pharma executive consultants, who gave their views on the data, along with practical maturation timing and barriers in pharma clinical development. |
|
|
|
| Demanding More From AI Governance In Drug Safety | White Paper | By Marie Flanagan, IQVIA Safety & Regulatory Compliance | Embedding AI governance into your safety system from the start empowers trust and streamlines the path toward success; it is merely the evolution of good data and risk governance. |
|
|
|
| From Raw Data To Real Insight | Brochure | Medidata, a Dassault Systemes company | Streamline clinical trials by unifying disparate data sources with AI-driven automation. Reduce manual effort and accelerate timelines to focus on patient safety and faster therapeutic delivery. |
|
|
| Connect With Clinical Leader: |
|
|
|
